[ Price : $8.95]
Federal Register notice: FDA posts a final guidance entitled Clinical Drug Interaction Studies With Combined Oral Contraceptives....[ Price : $8.95]
Federal Register notice: FDA announces the renewal of its Dermatologic and Ophthalmic Drugs Advisory Committee for an additional t...[ Price : $8.95]
Federal Register notice: FDA issues an order to permanently debar Analay Rico from providing services in any capacity related to a...[ Price : $8.95]
A group of bipartisan senators introduce the Promising Pathway Act, a bill to help Americans with amyotrophic lateral sclerosis (A...[ Price : $8.95]
Novartis urges FDA to broaden its proposal on patient preference information beyond medical devices.[ Price : $8.95]
FDA publishes a guidance with specifics about changes to user fees imposed under the GDUFA 3 reauthorization in 2022.[ Price : $8.95]
FDA approves a Novaliq NDA for Vevye (cyclosporine ophthalmic solution) 0.1% for treating the signs and symptoms of dry eye diseas...[ Price : $8.95]
Two SheppardMullin attorneys describe how two recent FDA guidances on pediatric drug development will tighten eligibility for pedi...